Trials / Completed
CompletedNCT02746133
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-027-CNI)
Characterisation of Patient Profile and Contemporary Treatment of Pre-dialytic Chronic Kidney Disease (CKD) in Patients Receiving a Restricted Protein Diet Supplemented With Ketosteril® - a Drug Utilisation Study (DUS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Fresenius Kabi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterise the patient and disease profile under the influence of a protein-restricted diet supplemented with keto acids/amino acids (KA/AA), focusing on the progression of chronic renal insufficiency, calcium and phosphorus metabolism, nutritional status, patient compliance to diet and Ketosteril intake as well as the persistent dietary education to ensure compliance in a large group of pre-dialysis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational study: Supplemented protein-restricted diet | Observational study: Supplemented protein-restricted diet |
Timeline
- Start date
- 2016-07-25
- Primary completion
- 2018-12-28
- Completion
- 2019-01-14
- First posted
- 2016-04-21
- Last updated
- 2019-02-01
Locations
2 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT02746133. Inclusion in this directory is not an endorsement.